ΚΥΑ 4616/52519 article. 15
Α. ACTIVE SUBSTANCES
- Evaluation of an active substance (chemical substance) for a single PT: 100.000 €.
- Evaluation of an active substance (microorganism) for a single PT: 50.000 €.
- Evaluation of an active substance (chemical compound) for additional PTs: 50.000 € / per PT.
- Evaluation of an active substance (microorganism) for additional PTs: 25.000 €/ PT.
- Evaluation of an active substance for inclusion in Annex I of BPR: 10.000 €.
- Renewal or Change in the conditions of approval of an active substance, which is included in Annex I of BPR, in case that Greece acts as Ref MS: 5.000 €.
- Change in the conditions of approval of an active substance, except for the PT, in case that Greece acts as Ref MS (10.000) €.
- Renewal of an active substance (chemical substance) in case that evaluation is required: 100.000 €.
- Renewal of an active substance (microorganism) in case that evaluation is required 50.000 €.
- Renewal of an active substance (chemical substance) in case that evaluation is not required: 50.000 €.
- Renewal of an active substance (microorganism) in case that evaluation is not required: 25.000 €.
- Evaluation of an approved active substance (chemical compound) for additional PTs: 50.000 € per PT.
- Evaluation of an approved active substance (microorganism) for additional PTs: 50.000 € per PT: 25.000 € per PT.
- Evaluation of an approved active substance (chemical compound) for additional PTs, but Greece was not the Ref MS: 75.000 € per PT.
- Evaluation of an approved active substance (chemical compound) for additional PTs, but Greece was not the Ref MS: 35.000 € per PT.
Β. BIOCIDAL PRODUCTS
UNION AUTHORIZATION (articles 41- 44 of BPR)
- Evaluation of a Biocidal product when Greece acts as RMS: 20.000 €.
- Evaluation of Biocidal product, which is the same as that used for the evaluation of the active substance and Greece acted as RMS: 4.000 €.
- Evaluation of a Biocidal product family when Greece acts as RMS 40.000 €.
NATIONAL AUTHORIZATION (articles 29 and 30 of BPR)
- Evaluation of a Biocidal product when Greece acts as RMS: 20.000 €.
- Evaluation of Biocidal product, which is the same as that used for the evaluation of the active substance and Greece acted as RMS: 4.000 €.
- Evaluation of Biocidal product, which is the same as that used for the evaluation of the active substance and Greece had not acted as RMS: 10.000 €.
- Evaluation of a Biocidal product family when Greece acts as RMS: 40.000 €.
- Notification of a new product belonging to an authorized family: 600 € per notification.
MUTUAL RECOGNITION PROCEDURE
- Mutual Recognition of Biocidal product: 2.500 €.
- Mutual Recognition of Biocidal product family: 5.000 €.
SIMPLIFIED PROCEDURE
- Evaluation of a Biocidal product according to the simplified procedure: 2.000 €.
- Evaluation of a Biocidal product according to the simplified procedure which was the same as that used for the evaluation of the active substance and Greece acted as RMS: 600 €.
- Evaluation of a Biocidal product according to the simplified procedure which was the same as that used for the evaluation of the active substance and Greece had not acted as RMS: 1.000 €.
- Evaluation of a Biocidal product family according to the simplified procedure: 4.000 €.
- Notification for placing on the market of a biocidal product that has been authorized in EU according to the simplified procedure: 400 €.
- Notification for placing on the market of a biocidal product family that has been authorized in EU according to the simplified procedure: 800 €.
- Addition of a new product to an already authorized Biocidal product family, which is authorized according to the simplified procedure: 200 €.
PROVISIONAL AUTHORIZATIONS (article 55.2 of BPR)
- Single biocidal product: 2.000 €.
- Single biocidal product, which is the same as that used in the evaluation of the active substance: 400 €.
- Biocidal product family: 4.000 €.
- Notification of a new product to an already authorized Biocidal product family: 200 €.
SAME BIOCIDAL PRODUCTS
- Single biocidal product: 1.600 €.
- Biocidal product family: 3.200 €.
CHANGES TO AUTHORIZATIONS
- Administrative change for a single Biocidal product: 200 € per product.
- Minor change for a single Biocidal product, when Greece acts as a RMS: 1.200 € per product.
- Minor change for a single Biocidal product, when Greece does not act as a RMS: 600 € per product.
- Major change for a single Biocidal product, when Greece acts as a RMS: 8.000 € per product.
- Major change for a single Biocidal product, when Greece does not act as a RMS 1.000 € per product.
- Major change for a single Biocidal product authorized according to Union Authorization, when Greece acts as a RMS 8.000 € per product.
- Administrative change for a Biocidal product family: 400 € per product family.
- Minor change for a Biocidal product family, when Greece acts as a RMS: 2.400 € per product family.
- Minor change for a Biocidal product family, when Greece does not act as a RMS1.200 € per product family.
- Major change for a Biocidal product family, when Greece acts as a RMS: 16.000 € per product family.
- Major change for a Biocidal product family, when Greece doesn’t act as a RMS:2.400 € per product family.
- Major change for a Biocidal product family authorized according to Union Authorization, when Greece acts as a RMS16.000 € per product family.
- Administrative change for a single Biocidal product authorized according to the simplified procedure: 200 € per product.
- Minor change for a single Biocidal product authorized according to the simplified procedure and Greece acts as RMS: 300 € per product.
- Minor change for a single Biocidal product authorized according to the simplified procedure and Greece does not act as RMS: 200 € per product.
- Major change for a single Biocidal product authorized according to the simplified procedure and Greece acts as RMS: 800 € per product.
- Major change for a single Biocidal product authorized according to the simplified procedure and Greece does not act as RMS: 300 € ανά προϊόν.
- Administrative change for a Biocidal product family authorized according to the simplified procedure: 300 € per product family.
- Minor change for a Biocidal product family authorized according to the simplified procedure and Greece acts as RMS: 600 € per product family.
- Minor change for a Biocidal product family authorized according to the simplified procedure and Greece does not act as RMS: 400 € per product family.
- Major change for a Biocidal product family authorized according to the simplified procedure and Greece acts as RMS: 1.600 € per product family.
- Major change for a Biocidal product family authorized according to the simplified procedure and Greece does not act as RMS: 600 € per product family.
RENEWALS OF THE BIOCIDAL PRODUCTS
NATIONAL AUTHORIZATIONS / UNION AUTHORIZATIONS
- Renewal of a single Biocidal product when evaluation is required: 15.000 €.
- Renewal of a Biocidal product family when evaluation is required: 30.000 €.
- Renewal of a single Biocidal product when evaluation is not required: 5.000 €.
- Renewal of a Biocidal product family when evaluation is not required: 10.000 €.
MUTUAL RECOGNITION
- Renewal of a single Biocidal product: 1.800 €.
- Renewal of a Biocidal product family: 3.600 €.
SIMPLIFIED PROCEDURE
- Renewal of a single Biocidal product when evaluation is required: 1500 €.
- Renewal of a Biocidal product family when evaluation is required: 3.000 €.
- Renewal of a single Biocidal product when evaluation is not required: 500 €.
- Renewal of a Biocidal product family when evaluation is not required: 1.000 €.
SAME PRODUCTS
- Renewal of a single Biocidal product: 200 €.
- Renewal of a Biocidal product family: 300 €.
MRLs
58. Evaluation of a data set (analytical methods, toxicological studies, residues) with a view to set Maximum Residue Limits (MRLs) for a non approved active substance:
α) Completeness check of the dossier: 500 €.
β) Evaluation of the data set: 2.000 €.
- Evaluation of a data set (analytical methods, toxicological studies, residues) with a view to set Maximum Residue Limits (MRLs) for an approved active substance:
α) Completeness check of the dossier: 500 €.
β) Evaluation of the data set: 2.000 €.
COMPARATIVE RISK ASSESSMENT
- Comparative risk assessment for Union Authorization Procedures for a single Biocidal product: 6.000 €
- Comparative risk assessment for Union Authorization Procedures for a Biocidal product family: 12.000 €
- Comparative risk assessment for National authorization for a single Biocidal product: 6.000 €
- Comparative risk assessment for National authorization for a Biocidal product family: 12.000 €
PARALLEL TRADE
- Fees for parallel trade: 2.000 €
EXPERIMENTAL PERMIT
- Fees for experimental permit: 500 €
1